Top

Published in:

01-11-2020 | Urological Surgery | Original Article

The LACE + index as a predictor of 90-day urologic surgery outcomes

Authors: Gregory Glauser, Eric Winter, Ian F. Caplan, Debanjan Haldar, Stephen Goodrich, Scott D. McClintock, Thomas J. Guzzo, Neil R. Malhotra

Published in: World Journal of Urology | Issue 11/2020

Abstract

Purpose

This study assessed the ability of the LACE + [Length of stay, Acuity of admission, Charlson Comorbidity Index (CCI) score, and Emergency department visits in the past 6 months] index to predict adverse outcomes after urologic surgery.

Methods

LACE + scores were retrospectively calculated for all consecutive patients (n = 9824) who received urologic surgery at one multi-center health system over 2 years (2016–2018). Coarsened exact matching was employed to sort patient data before analysis; matching criteria included duration of surgery, BMI, and race among others. Outcomes including unplanned hospital readmission, emergency room visits, and reoperation were compared for patients with different LACE + quartiles.

Results

722 patients were matched between Q1 and Q4; 1120 patients were matched between Q2 and Q4; 2550 patients were matched between Q3 and Q4. Higher LACE + score significantly predicted readmission within 90 days (90D) of discharge for Q1 vs Q4 and Q2 vs Q4. Increased LACE + score also significantly predicted 90D emergency room visits for Q1 vs Q4, Q2 vs Q4, and Q3 vs Q4. LACE + score was also significantly predictive of 90D reoperation for Q1 vs Q4. LACE + score did not predict 90D reoperation for Q2 vs Q4 or Q3 vs Q4 or 90D readmission for Q3 vs. Q4.

Conclusion

These results suggest that LACE + may be a suitable prediction model for important patient outcomes after urologic surgery.

Available only for authorised users

Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med 360:1418–1428. https://doi.org/10.1056/NEJMsa0803563CrossRef

Axon RN, Williams MV (2011) Hospital readmission as an accountability measure. JAMA 305:504–505. https://doi.org/10.1001/jama.2011.72CrossRef

Kocher RP, Adashi EY (2011) Hospital readmissions and the affordable care act: paying for coordinated quality care. JAMA 306:1794–1795. https://doi.org/10.1001/jama.2011.1561CrossRef

Rambachan A, Matulewicz RS, Pilecki M et al (2014) Predictors of readmission following outpatient urological surgery. J Urol 192:183–188. https://doi.org/10.1016/j.juro.2013.12.053CrossRef

Baack Kukreja J, Kamat AM (2017) Strategies to minimize readmission rates following major urologic surgery. Ther Adv Urol 9:111–119. https://doi.org/10.1177/1756287217701699CrossRef

Al-Daghmin A, Aboumohamed A, Din R et al (2014) Readmission after robot-assisted radical cystectomy: outcomes and predictors at 90-day follow-up. Urology 83:350–356. https://doi.org/10.1016/j.urology.2013.09.056CrossRef

Schmid M, Chiang HA, Sood A et al (2016) Causes of hospital readmissions after urologic cancer surgery. Urol Oncol 34:236.e1–11. https://doi.org/10.1016/j.urolonc.2015.11.019CrossRef

Chappidi MR, Kates M, Stimson CJ et al (2017) Causes, timing, hospital costs and perioperative outcomes of index vs nonindex hospital readmissions after radical cystectomy: implications for regionalization of care. J Urol 197:296–301. https://doi.org/10.1016/j.juro.2016.08.082CrossRef

Chappidi MR, Kates M, Stimson CJ et al (2017) Quantifying nonindex hospital readmissions and care fragmentation after major urological oncology surgeries in a nationally representative sample. J Urol 197:235–240. https://doi.org/10.1016/j.juro.2016.07.078CrossRef

10.

Stimson CJ, Chang SS, Barocas DA et al (2010) Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol 184:1296–1300. https://doi.org/10.1016/j.juro.2010.06.007CrossRef

11.

Hu M, Jacobs BL, Montgomery JS et al (2014) Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer. Cancer 120:1409–1416. https://doi.org/10.1002/cncr.28586CrossRef

12.

Leow JJ, Gandaglia G, Sood A et al (2014) Readmissions after major urologic cancer surgery. Can J Urol 21:7537–7546

13.

van Walraven C, Dhalla IA, Bell C et al (2010) Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ 182:551–557. https://doi.org/10.1503/cmaj.091117CrossRef

14.

van Walraven C, Wong J, Forster AJ (2012) LACE+ index: extension of a validated index to predict early death or urgent readmission after hospital discharge using administrative data. Open Med 6:e80–e90

15.

El Morr C, Ginsburg L, Nam V-S et al (2016) Analyzing readmissions patterns: assessment of the LACE tool impact. Stud Health Technol Inform 223:25–30

16.

Damery S, Combes G (2017) Evaluating the predictive strength of the LACE index in identifying patients at high risk of hospital readmission following an inpatient episode: a retrospective cohort study. BMJ Open 7:e016921. https://doi.org/10.1136/bmjopen-2017-016921CrossRef

17.

Caplan IF, Sullivan PZ, Kung D et al (2019) LACE+ index as predictor of 30-day readmission in brain tumor population. World Neurosurg. https://doi.org/10.1016/j.wneu.2019.03.169CrossRef

18.

Staman K, Schorr C, Kaur D, Hunter K (2019) 1571: does the LACE + perform better than the Charlson comorbidity index to predict sepsis readmission? Crit Care Med 47:761. https://doi.org/10.1097/01.ccm.0000552314.49684.aeCrossRef

19.

Caplan IF, Zadnik Sullivan P, Glauser G et al (2019) The LACE+ index fails to predict 30–90 day readmission for supratentorial craniotomy patients: a retrospective series of 238 surgical procedures. Clin Neurol Neurosurg 182:79–83. https://doi.org/10.1016/j.clineuro.2019.04.026CrossRef

20.

Iacus SM, King G, Porro G (2012) causal inference without balance checking: coarsened exact matching. Polit Anal 20:1–24. https://doi.org/10.1093/pan/mpr013CrossRef

21.

Gawande A (2018) Why Doctors Hate Their Computers

22.

Autorino R, Zargar H, Butler S et al (2015) Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the National Surgical Quality Improvement Program database. Urology 85:843–849. https://doi.org/10.1016/j.urology.2014.11.044CrossRef

23.

Dawes AJ, Sacks GD, Russell MM et al (2014) Preventable Readmissions to Surgical Services: Lessons Learned and Targets for Improvement. J Am Coll Surg 219:382–389. https://doi.org/10.1016/j.jamcollsurg.2014.03.046CrossRef

24.

Burke RE, Coleman EA (2013) Interventions to decrease hospital readmissions: keys for cost-effectiveness. JAMA Intern Med 173:695–698. https://doi.org/10.1001/jamainternmed.2013.171CrossRef

25.

Hansen LO, Young RS, Hinami K et al (2011) Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med 155:520. https://doi.org/10.7326/0003-4819-155-8-201110180-00008CrossRef

26.

Kim JYS, Khavanin N, Rambachan A et al (2015) Surgical duration and risk of venous thromboembolism. JAMA Surg 150:110–117. https://doi.org/10.1001/jamasurg.2014.1841CrossRef

27.

Causey MW, McVay D, Hatch Q et al (2013) The impact of race on outcomes following emergency surgery: an American College of Surgeons National Surgical Quality Improvement Program assessment. Am J Surg 206:172–179. https://doi.org/10.1016/j.amjsurg.2012.11.022CrossRef

28.

Wilson JR, Tetreault LA, Schroeder G et al (2017) Impact of elevated body mass index and obesity on long-term surgical outcomes for patients with degenerative cervical myelopathy: analysis of a combined prospective dataset. Spine 42:195–201. https://doi.org/10.1097/BRS.0000000000001859CrossRef

29.

Connolly TM, White RS, Sastow DL et al (2018) The disparities of coronary artery bypass grafting surgery outcomes by insurance status: a retrospective cohort study, 2007–2014. World J Surg 42:3240–3249. https://doi.org/10.1007/s00268-018-4631-9CrossRef

30.

LaPar DJ, Bhamidipati CM, Harris DA et al (2011) Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States. Ann Thorac Surg 92:434–439. https://doi.org/10.1016/j.athoracsur.2011.04.048CrossRef

Title: The LACE + index as a predictor of 90-day urologic surgery outcomes
Authors: Gregory Glauser
Eric Winter
Ian F. Caplan
Debanjan Haldar
Stephen Goodrich
Scott D. McClintock
Thomas J. Guzzo
Neil R. Malhotra
Publication date: 01-11-2020
Publisher: Springer Berlin Heidelberg
Keywords: Urological Surgery
Urological Surgery
Published in: World Journal of Urology / Issue 11/2020
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-019-03064-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The LACE + index as a predictor of 90-day urologic surgery outcomes

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2020

Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity?

The efficacy of medical dissolution therapy for uric acid nephrolithiasis

Current perspectives on urolithiasis management in China

The fate of urological systematic reviews registered in PROSPERO

Higher expression of phosphodiesterase type 5 in the anterior fibromuscular stroma of the human prostate

Treatment of urinary tract infections in the old and fragile